NeuroBo Pharmaceuticals
a novel protein coupled receptor agonist with potential for non alcoholic nash synthetic small molecule selective and suitable for oral administration i ale | NeuroBo Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
8 of 30
Related slides by other companies
Avenue Therapeutics
IPO
October 2022
is a selective receptor agonist that produces and activity receptor | Avenue Therapeutics
Other recent decks by NeuroBo Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
March 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io